bristol myers squibb

Bristol-Myers Squibb Reacquires Rights To ASLAN Drug

Bristol-Myers Squibb will be reacquiring the rights to ASLAN002, a gastric and breast cancer drug, for several APAC markets.

GIS & Pryobett To Develop Pyrosequencing For Clinical Diagnostics

The novel pyrosequencing platform can perform real-time sequencing for quicker medical decision-making.

BMS Foundation Awards US$3.5 Million In Hepatitis Grants

Bristol-Myers Squibb has awarded US$3.5 million in grants to tackle the 'silent epidemic' of hepatitis in India and China.

Bristol-Myers Squibb, Kyowa Hakko Kirin To Commercialize Coniel In China

Bristol-Myers Squibb and Kyowa Hakko Kirin will commercialize Coniel, a calcium channel blocker for the treatment of hypertension and angina pectoris, in China.

Samsung BioLogics To Manufacture Antibody Drug For Bristol-Myers Squibb

Samsung BioLogics will manufacture a commercial antibody cancer drug for Bristol-Myers Squibb at its Songdo Incheon plant in South Korea.

BMS, Simcere Pharma To Co-Develop Orencia® SC In China

BMS and Simcere will co-develop and co-commercialize the subcutaneous formulation of Orencia® for the treatment of rheumatoid arthritis in China.

Bristol-Myers Squibb Awards Four Grants For Hepatitis Education

To mark World Hepatitis Day 2012, the Bristol-Myers Squibb Foundation has awarded four new grants focused on Hepatitis B and Hepatitis C research in China and India.

Bristol-Myers Squibb And Tsinghua University Enter Research Partnership

Bristol-Myers Squibb Company and Tsinghua University of Beijing, China, announced this Monday the formation of a multi-year research partnership.

Bristol-Myers Squibb To Support Hepatitis B, C Research In Asia

The Bristol-Myers Squibb Foundation has awarded three new grants to further research into hepatitis B and C in China and India.

Simcere Pharma & BMS To Develop CETP Inhibitor BMS-795311

BMS and Simcere Pharma have agreed to co-develop BMS-795311, a preclinical small molecule inhibitor of the cholesteryl ester transfer protein.